Prevnar 13 Pneumococcal Vaccine, 0.5 mL

Prevnar 13 Pneumococcal Vaccine, 0.5 mL

Prevnar 13 is a pneumococcal conjugate vaccine designed to protect individuals against invasive diseases and pneumonia caused by 13 strains of Streptococcus pneumoniae. This vaccine is formulated for active immunization and is a critical component in the fight against pneumococcal diseases.

Product Specifications:
- Dosage Form: Injection, supplied in a 0.5 mL single-dose pre-filled syringe.
- Active Ingredients: Contains polysaccharides from 13 serotypes of Streptococcus pneumoniae, conjugated to CRM197 protein.
- Preservative: None, this is a preservative-free formulation.
- Storage: Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze.
- Shelf Life: Check the expiration date on the label; do not use beyond this date.

Common Applications:
- Target User Groups: Indicated for individuals 6 weeks of age and older, including children, adults, and the elderly.
- Preventative Care: Recommended for prevention of pneumococcal pneumonia and invasive diseases such as bacteremia and meningitis.
- Public Health: Utilized in national immunization programs and by healthcare providers worldwide.

Overview of Pfizer:
Pfizer is a global pharmaceutical leader renowned for its commitment to innovation and the development of high-quality vaccines and medications. With a legacy spanning over 170 years, Pfizer has established itself as an authority in the pharmaceutical industry, particularly in the vaccine space. Their dedication to rigorous scientific research, patient safety, and the advancement of public health initiatives positions them at the forefront of vaccine development and distribution. Prevnar 13 is a testament to Pfizer's expertise in creating vaccines that address significant health challenges and protect populations against infectious diseases.